The effectiveness of fecal microbiota transplantation (FMT) in combination with anti-PD-1 in melanoma patients was previously studied in clinical study to determine whether changing the gut microbiota may help treat anti-PD-1 resistance. Here, PDCD1 is linked to melanoma.